Clinical and Lab Diagnostics - Tariffs, Supply Chain Disruptions, and Evolving Regulations
View as a Web Page
News Medical
 
  Clinical and Lab Diagnostics Clinical and Lab Diagnostics logo  
  The latest clinical and lab diagnostics news from News Medical  
 

The Hidden Value of Stool Samples in Multi-Omics ResearchThe Hidden Value of Stool Samples in Multi-Omics Research

Stool samples are a rich source of biological information, offering insights into gut health, disease biomarkers, and host-microbiome interactions. Advances in multi-omics are unlocking its diagnostic potential for conditions ranging from metabolic disorders to neurodegenerative diseases, and even cancer.
In this eBook, learn best practices for extracting high-quality DNA, RNA, miRNA, and EVs from fecal samples to support impactful research and diagnostics.

Download the eBook
 
 
    Tariffs, Supply Chain Disruptions, and Evolving RegulationsTariffs, Supply Chain Disruptions, and Evolving Regulations
 
Join Dr. Todd Bauman, Sr. Director of Supply Chain at Ascential Medical & Life Sciences, for an expert-led webinar that breaks down key supply chain models and how to choose between them for sustainable success.

Dr. Bauman will provide the insights you need to optimize your manufacturing footprint, reduce risk, and improve your bottom line.

 
Book Your Place Today
 
 
   New Blood Test Could Revolutionize Alzheimer’s DiagnosisNew Blood Test Could Revolutionize Alzheimer’s Diagnosis
 
Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible blood-based testing in healthcare.
 
   Sex and age play key roles in dementia biomarker levelsSex and age play key roles in dementia biomarker levels
 
A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a study published on April 16, 2025, online in Neurology, the medical journal of the American Academy of Neurology.
 
 Prostate cancer diagnosis is not a death sentence, study says
 
Prostate cancer diagnosis is not a death sentence, study saysProstate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022.
 
 
 New RNA-based diagnostics to fight against tuberculosis
 
New RNA-based diagnostics to fight against tuberculosisIn 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent antibiotics can eradicate the Mycobacterium tuberculosis bacteria.
 
 
 Age and sex shape Alzheimer’s blood biomarkers, study finds
 
Age and sex shape Alzheimer’s blood biomarkers, study findsESTHER study found that non-modifiable factors like age, sex, and APOE ε4 status significantly influence blood biomarker levels linked to Alzheimer’s disease. GFAP and NfL levels, in particular, showed strong age- and sex-related patterns, with GFAP levels rising faster in women.
 
 
 AI model enhances early diagnosis of multiple sclerosis
 
AI model enhances early diagnosis of multiple sclerosisTo provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three years too late.
 
 
 New biomarkers identified for early detection of gynecological cancer
 
New biomarkers identified for early detection of gynecological cancerResearchers from the University of Skövde, the University of Gothenburg, and the Sahlgrenska Academy have significantly advanced early detection of gynecological cancer.
 
 
 Study identifies DNA methylation entropy as a biomarker for aging
 
Study identifies DNA methylation entropy as a biomarker for agingA new research paper was published in Aging (Aging-US) Volume 17, Issue 3, on March 12, 2025, titled "DNA methylation entropy is a biomarker for aging."
 
 
 New method improves RMST analysis for clinical and epidemiological studies
 
New method improves RMST analysis for clinical and epidemiological studiesThe restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and since then has become widely used in economics, engineering, business and other professions.
 
 
 New subtype of Castleman disease identified to improve diagnosis and treatment
 
New subtype of Castleman disease identified to improve diagnosis and treatmentA newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been caught between existing classification systems, marking the first major discovery of its kind in 45 years.
 
 
 Serum hsa_circ_101555 as a promising biomarker for hepatocellular carcinoma
 
Serum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking. Circular RNAs (circRNAs) are one of the promising biomarkers.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025